Skip to main content
Erschienen in: Journal of Gastroenterology 4/2014

01.04.2014 | Original Article—Liver, Pancreas, and Biliary Tract

New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography

verfasst von: Hironori Tanaka, Hiroko Iijima, Akiko Higashiura, Kazunori Yoh, Akio Ishii, Tomoyuki Takashima, Yoshiyuki Sakai, Nobuhiro Aizawa, Kazunari Iwata, Naoto Ikeda, Yoshinori Iwata, Hirayuki Enomoto, Masaki Saito, Hiroyasu Imanishi, Seiichi Hirota, Jiro Fujimoto, Shuhei Nishiguchi

Erschienen in: Journal of Gastroenterology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The ultrasonography contrast agent Sonazoid provides parenchyma-specific contrast imaging (Kupffer imaging) based on its accumulation in Kupffer cells. This agent also facilitates imaging of the fine vascular architecture in tumors through maximum intensity projection (MIP). We examined the clinical utility of the malignancy grading system for hepatocellular carcinoma (HCC) using a combination of 2 different contrast-enhanced ultrasonography images.

Methods

We studied 121 histologically confirmed cases of HCC (well-differentiated, 45; moderately differentiated, 70; poorly differentiated, 6). The results of Kupffer imaging were classified as (1) iso-echoic pattern or (2) hypo-echoic pattern. The MIP patterns produced were classified into one of the following categories: fine, tumor vessels were not clearly visualized and only fine vessels were visualized; vascular, tumor vessels were visualized clearly; irregular, tumor vessels were thick and irregular. Based on the combined assessment of Kupffer imaging and the MIP pattern, the samples were classified into 4 grades: Grade 1 (iso-fine/vascular), Grade 2 (hypo-fine), Grade 3 (hypo-vascular), and Grade 4 (hypo-irregular).

Results

The distribution of moderately and poorly differentiated HCCs was as follows: Grade 1, 4 % (1/24); Grade 2, 52 % (15/29); Grade 3, 85 % (44/52); and Grade 4, 100 % (16/16). The grading system also predicted portal vein invasion in 72 resected HCCs: Grade 1, 0 % (0/4); Grade 2, 13 % (1/8); Grade 3, 23 % (11/48); and Grade 4, 67 % (8/12).

Conclusions

This new malignant grading system is useful for estimation of histological differentiation and portal vein invasion of HCC.
Literatur
1.
Zurück zum Zitat El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.PubMedCrossRef El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.PubMedCrossRef
2.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef
3.
Zurück zum Zitat Tamura S, Kato T, Berho M, Misiakos EP, O’Brien C, Reddy KR, et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg. 2001;136:25–30 Discussion 31.PubMedCrossRef Tamura S, Kato T, Berho M, Misiakos EP, O’Brien C, Reddy KR, et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg. 2001;136:25–30 Discussion 31.PubMedCrossRef
4.
Zurück zum Zitat Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology. 1997;25:87–92.PubMedCrossRef Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology. 1997;25:87–92.PubMedCrossRef
5.
Zurück zum Zitat Sakurai M, Okamura J, Seki K, Kuroda C. Needle tract implantation of hepatocellular carcinoma after percutaneous liver biopsy. Am J Surg Pathol. 1983;7:191–5.PubMedCrossRef Sakurai M, Okamura J, Seki K, Kuroda C. Needle tract implantation of hepatocellular carcinoma after percutaneous liver biopsy. Am J Surg Pathol. 1983;7:191–5.PubMedCrossRef
6.
Zurück zum Zitat Smith EH. Complications of percutaneous abdominal fine-needle biopsy. Review. Radiology. 1991;178:253–8.PubMed Smith EH. Complications of percutaneous abdominal fine-needle biopsy. Review. Radiology. 1991;178:253–8.PubMed
7.
Zurück zum Zitat Watanabe R, Matsumura M, Chen CJ, Kaneda Y, Ishihara M, Fujimaki M. Gray-scale liver enhancement with Sonazoid (NC100100), a novel ultrasound contrast agent; detection of hepatic tumors in a rabbit model. Biol Pharm Bull. 2003;26:1272–7.PubMedCrossRef Watanabe R, Matsumura M, Chen CJ, Kaneda Y, Ishihara M, Fujimaki M. Gray-scale liver enhancement with Sonazoid (NC100100), a novel ultrasound contrast agent; detection of hepatic tumors in a rabbit model. Biol Pharm Bull. 2003;26:1272–7.PubMedCrossRef
8.
Zurück zum Zitat Hagen EK, Forsberg F, Aksnes AK, Merton DA, Liu JB, Tornes A, et al. Enhanced detection of blood flow in the normal canine prostate using an ultrasound contrast agent. Invest Radiol. 2000;35:118–24.PubMedCrossRef Hagen EK, Forsberg F, Aksnes AK, Merton DA, Liu JB, Tornes A, et al. Enhanced detection of blood flow in the normal canine prostate using an ultrasound contrast agent. Invest Radiol. 2000;35:118–24.PubMedCrossRef
9.
Zurück zum Zitat Yao J, Teupe C, Takeuchi M, Avelar E, Sheahan M, Connolly R, et al. Quantitative 3-dimensional contrast echocardiographic determination of myocardial mass at risk and residual infarct mass after reperfusion: experimental canine studies with intravenous contrast agent NC100100. J Am Soc Echocardiogr. 2000;13:570–81.PubMedCrossRef Yao J, Teupe C, Takeuchi M, Avelar E, Sheahan M, Connolly R, et al. Quantitative 3-dimensional contrast echocardiographic determination of myocardial mass at risk and residual infarct mass after reperfusion: experimental canine studies with intravenous contrast agent NC100100. J Am Soc Echocardiogr. 2000;13:570–81.PubMedCrossRef
10.
Zurück zum Zitat Korenaga K, Korenaga M, Furukawa M, Yamasaki T, Sakaida I. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol. 2009;44:733–41.PubMedCrossRef Korenaga K, Korenaga M, Furukawa M, Yamasaki T, Sakaida I. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol. 2009;44:733–41.PubMedCrossRef
11.
Zurück zum Zitat Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology. 2000;32:205–12.PubMedCrossRef Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology. 2000;32:205–12.PubMedCrossRef
12.
Zurück zum Zitat Inoue T, Kudo M, Watai R, Pei Z, Kawasaki T, Minami Y, et al. Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol. 2005;40:1139–47.PubMedCrossRef Inoue T, Kudo M, Watai R, Pei Z, Kawasaki T, Minami Y, et al. Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol. 2005;40:1139–47.PubMedCrossRef
13.
Zurück zum Zitat Wilson SR, Jang HJ, Kim TK, Iijima H, Kamiyama N, Burns PN. Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. Am J Roentgenol. 2008;190:691–5.CrossRef Wilson SR, Jang HJ, Kim TK, Iijima H, Kamiyama N, Burns PN. Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. Am J Roentgenol. 2008;190:691–5.CrossRef
14.
Zurück zum Zitat Sugimoto K, Moriyasu F, Kamiyama N, Metoki R, Yamada M, Imai Y, et al. Analysis of morphological vascular changes of hepatocellular carcinoma by microflow imaging using contrast-enhanced sonography. Hepatol Res. 2008;38:790–9.PubMedCrossRef Sugimoto K, Moriyasu F, Kamiyama N, Metoki R, Yamada M, Imai Y, et al. Analysis of morphological vascular changes of hepatocellular carcinoma by microflow imaging using contrast-enhanced sonography. Hepatol Res. 2008;38:790–9.PubMedCrossRef
15.
Zurück zum Zitat Terminology of nodular hepatocellular lesions. International Working Party. Hepatology. 1995;22:983–93. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology. 1995;22:983–93.
16.
Zurück zum Zitat Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. Am J Roentgenol. 1999;172:969–76.CrossRef Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. Am J Roentgenol. 1999;172:969–76.CrossRef
17.
Zurück zum Zitat Johnson CM, Sheedy PF, Stanson AW, Stephens DH, Hattery RR, Adson MA. Computed tomography and angiography of cavernous hemangiomas of the liver. Radiology. 1981;138:115–21.PubMed Johnson CM, Sheedy PF, Stanson AW, Stephens DH, Hattery RR, Adson MA. Computed tomography and angiography of cavernous hemangiomas of the liver. Radiology. 1981;138:115–21.PubMed
18.
Zurück zum Zitat Wen YL, Kudo M, Zheng RQ, Ding H, Zhou P, Minami Y, et al. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. Am J Roentgenol. 2004;182:1019–26.CrossRef Wen YL, Kudo M, Zheng RQ, Ding H, Zhou P, Minami Y, et al. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. Am J Roentgenol. 2004;182:1019–26.CrossRef
Metadaten
Titel
New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography
verfasst von
Hironori Tanaka
Hiroko Iijima
Akiko Higashiura
Kazunori Yoh
Akio Ishii
Tomoyuki Takashima
Yoshiyuki Sakai
Nobuhiro Aizawa
Kazunari Iwata
Naoto Ikeda
Yoshinori Iwata
Hirayuki Enomoto
Masaki Saito
Hiroyasu Imanishi
Seiichi Hirota
Jiro Fujimoto
Shuhei Nishiguchi
Publikationsdatum
01.04.2014
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 4/2014
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-013-0830-1

Weitere Artikel der Ausgabe 4/2014

Journal of Gastroenterology 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.